Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic LeukemiaMichael J. Keating, Hagop M. Kantarjian, Susan O’Brien et al.|Journal of Clinical Oncology|2005Cited by 951
Ibrutinib and Venetoclax for First-Line Treatment of CLLNitin Jain, William G. Wierda, Musa Yılmaz et al.|New England Journal of Medicine|2019Cited by 502
Fludarabine: a new agent with major activity against chronic lymphocytic leukemiaMJ Keating, KB McCredie, H. Kantarjian et al.|Blood|1989Cited by 456
Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell deathRong Chen, William Plunkett|Blood|2005Cited by 253
Repair of 2′- <i>C</i> -Cyano-2′-Deoxy-1-β- <scp>d</scp> - <i>arabino</i> -Pentofuranosylcytosine–Induced DNA Single-Strand Breaks by Transcription-Coupled Nucleotide Excision RepairYaqing Wang, William Plunkett|Cancer Research|2008Cited by 23